Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial

BACKGROUND: The value of chemotherapy in soft tissue sarcoma (STS) remains controversial. Several expert teams consider that chemotherapy provides a survival advantage and should be proposed in high-risk (HR) patients. However, the lack of accuracy in identifying HR patients with conventional risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Filleron, Thomas, Le Guellec, Sophie, Chevreau, Christine, Cabarrou, Bastien, Lesluyes, Tom, Lodin, Sabrina, Massoubre, Angélique, Mounier, Muriel, Poublanc, Muriel, Chibon, Frédéric, Valentin, Thibaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395339/
https://www.ncbi.nlm.nih.gov/pubmed/32736540
http://dx.doi.org/10.1186/s12885-020-07207-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395339/
https://www.ncbi.nlm.nih.gov/pubmed/32736540
http://dx.doi.org/10.1186/s12885-020-07207-3

Ejemplares similares